Verdad Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Verdad Advisers's ELV Position: Q3 2026 in Review
Verdad Advisers opened a new position in Elevance Health (ELV) in Q3 2026: 1,165 shares worth $453K. The stake represents 0.49% of the portfolio and ranks #75 among its holdings. This is a return to the name: Verdad Advisers previously reported a position in ELV as recently as Q1 2026.
Verdad Advisers first reported a position in ELV in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.63M in Q2 2024. 1,616 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Verdad Advisers held 1,165 shares of Elevance Health worth $453K as of Q3 2026.
- Elevance Health was a new Verdad Advisers position in Q3 2026.
- Elevance Health made up 0.49% of Verdad Advisers's portfolio in Q3 2026, its #75 holding.
- Verdad Advisers first reported a position in Elevance Health in Q1 2024 and has held it in 5 quarters since.
- Verdad Advisers's Elevance Health position peaked at $1.63M in Q2 2024.
- 1,616 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.